FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3645711000001104: Spironolactone 50mg / Furosemide 20mg capsules 28 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22297301000001112 Spironolactone 50mg / Furosemide 20mg capsules 28 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22297401000001116 Spironolactone 50mg / Furosemide 20mg capsules 28 capsule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Is pack of Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule false Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has active ingredient Spironolactone false Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has active ingredient Furosemide false Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has VMP Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has specific active ingredient Furosemide true Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has specific active ingredient Spironolactone true Inferred relationship Existential restriction modifier
Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lasilactone capsules (Borg Medicare Ltd) 28 capsule 2 x 14 capsules Is a True Spironolactone 50mg / Furosemide 20mg capsules 28 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start